TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

BlackRock, Inc.'s Holding History (CIK: 0002012383)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 3,675,000 Value ($000) $5,226 Avg Close — Range —
Q3 2025
Shares 3,175,000 Value ($000) $3,580 Avg Close — Range —
Q2 2025
Shares 3,175,000 Value ($000) $3,016 Avg Close — Range —
Q1 2025
Shares 3,250,000 Value ($000) $3,231 Avg Close — Range —
Q4 2024
Shares 3,625,000 Value ($000) $3,452 Avg Close — Range —
Q3 2024
Shares 2,725,000 Value ($000) $2,341 Avg Close — Range —